Skip to main content

Update on health care reform

The following update is from the American Thoracic Society newsletter. If I get a chance, I might comment later. For now, I know its hard to figure out what exactly is going on with this issue. I for one, am very confused about the current state of the bill, what's in and what's out.

Thus, I'm not posting this as a pro or a con - it's just a nice summary of what's going on.


Congressional Leaders Close to Deal on Health Reform Bill
Following Senate passage of healthcare reform legislation on December 24, House and Senate leaders are negotiating between each chamber and with the President to produce final legislation. Instead of a formal House-Senate conference on the bill, the leadership and chairs of the relevant House and Senate committees are meeting and working informally to produce a final bill, a process known as "ping-pong."
Late yesterday, an agreement with Labor leaders was forged on one of the "pay for" mechanisms in the bill, the tax on high-cost insurance plans. Under the deal, the threshold for a new 40 percent tax on high-cost insurance plans was increased from $8,500 to $8,900 for individual plans and from $23,000 to $24,000 for family plans. An important new point in the deal is that these levels will be adjusted for inflation annually.


Another key issue that remains to be resolved is whether the health insurance exchange will be a national entity or state-based. Other issues still being negotiated include Medicare prescription coverage and abortion language. Many House Democrats are also still working to preserve some form of a public health insurance option in the bill.The option, as currently envisioned, does not have enough support to pass the Senate.

The ATS Washington Office is working to ensure that a number of key measures are included in the final legislation, including a House-passed measure to extend coverage of tobacco cessation services to all Medicaid beneficiaries, measures to increase patient access to clinical research participation, measures to address physician workforce shortages, including education incentives for pediatric specialties and funding for prevention programs.

There are a series of other issues that the ATS has actively advocated for throughout the debate, but to our disappointment are no longer in play at this final stage of negotiations. These issues include the public insurance option, Medicare coverage of end-of-life counseling and medical liability reform. Although these issues are unlikely to appear in the final health reform bill, the ATS will continue to advocate for these measures.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria